DIRAS3 enhances RNF19B-mediated RAC1 ubiquitination and degradation in non-small-cell lung cancer cells

被引:2
作者
Wang, Yingying [1 ]
Wei, Minli [1 ]
Su, Min [1 ]
Du, Zhiyuan [1 ]
Dong, Jiaxi [1 ]
Zhang, Yu [1 ]
Wu, Yingdi [1 ]
Li, Xiaopeng [1 ]
Su, Ling [1 ]
Liu, Xiangguo [1 ,2 ]
机构
[1] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao, Peoples R China
[2] Shandong Univ, Key Lab, Minist Educ Expt Teratol, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-SUPPRESSOR GENE; LYTIC-ASSOCIATED MOLECULE; LIGASE NKLAM; ARHI; OVARIAN; MIGRATION; EXPRESSION; PROGRESSION; PROTEIN; GROWTH;
D O I
10.1016/j.isci.2023.107157
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Distant metastasis remains the leading cause of high mortality in patients with non-small-cell lung cancer (NSCLC). DIRAS3 is a candidate tumor suppressor protein that is decreased in various tumors. However, the regulatory mechanism of DIRAS3 on metastasis of NSCLC remains unclear. Here, we found that DIRAS3 suppressed the migration of NSCLC cells. Besides, DIRAS3 stimulated the polyubiquitination of RAC1 and suppressed its protein expression. Furthermore, RNF19B, a member of the RBR E3 ubiquitin ligase family, was observed to be the E3 ligase involved in the DIRAS3-induced polyubiquitination of RAC1. DIRAS3 could promote the binding of RAC1 and RNF19B, thus enhancing the degradation of RAC1 by the ubiquitin-proteasome pathway. Finally, the DIRAS3-RNF19B-RAC1 axis was confirmed to be associated with the malignant progression of NSCLC. These findings may be beneficial for developing potential prognostic markers of NSCLC and may provide an effective treatment strategy.
引用
收藏
页数:19
相关论文
共 49 条
[1]  
[Anonymous], 2003, AB METH SIL ARHI IMP
[2]  
[Anonymous], 2002, REEXPR TUM SUPPR GEN
[3]   Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer [J].
Arbour, Kathryn C. ;
Mezquita, Laura ;
Long, Niamh ;
Rizvi, Hira ;
Auclin, Edouard ;
Ni, Andy ;
Martinez-Bernal, Gala ;
Ferrara, Roberto ;
Lai, W. Victoria ;
Hendriks, Lizza E. L. ;
Sabari, Joshua K. ;
Caramella, Caroline ;
Plodkowski, Andrew J. ;
Halpenny, Darragh ;
Chaft, Jamie E. ;
Planchard, David ;
Riely, Gregory J. ;
Besse, Benjamin ;
Hellmann, Matthew D. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (28) :2872-+
[4]   The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways [J].
Badgwell, D. B. ;
Lu, Z. ;
Le, K. ;
Gao, F. ;
Yang, M. ;
Suh, G. K. ;
Bao, J-J ;
Das, P. ;
Andreeff, M. ;
Chen, W. ;
Yu, Y. ;
Ahmed, A. A. ;
Liao, W. S-L ;
Bast, R. C., Jr. .
ONCOGENE, 2012, 31 (01) :68-79
[5]   DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy [J].
Bildik, Gamze ;
Liang, Xiaowen ;
Sutton, Margie N. ;
Bast, Robert C., Jr. ;
Lu, Zhen .
MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) :25-37
[6]   Rac1 GTPase: A "Rac" of All Trades [J].
Bosco, E. E. ;
Mulloy, J. C. ;
Zheng, Y. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (03) :370-374
[7]   Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors [J].
Dalai, Irene ;
Missiaglia, Edoardo ;
Barbi, Stefano ;
Butturini, Giovanni ;
Doglioni, Claudio ;
Falconi, Massimo ;
Scarpa, Aldo .
NEOPLASIA, 2007, 9 (03) :181-U2
[8]   RING-Between-RING E3 Ligases: Emerging Themes amid the Variations [J].
Dove, Katja K. ;
Klevit, Rachel E. .
JOURNAL OF MOLECULAR BIOLOGY, 2017, 429 (22) :3363-3375
[9]   Rho GTPases in cell biology [J].
Etienne-Manneville, S ;
Hall, A .
NATURE, 2002, 420 (6916) :629-635
[10]   Rac1 regulates cardiovascular development and postnatal function of endothelium [J].
Fiedler, Lorna R. .
CELL ADHESION & MIGRATION, 2009, 3 (02) :143-145